Cargando…
TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors
Binding of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to the plasma membrane TRAIL-R1/-R2 selectively kills tumor cells. This discovery led to evaluation of TRAIL-R1/-R2 as targets for anti-cancer therapy, yet the corresponding clinical trials were disappointing. Meanwhile, it e...
Autores principales: | Mert, Ufuk, Adawy, Alshaimaa, Scharff, Elisabeth, Teichmann, Pierre, Willms, Anna, Haselmann, Verena, Colmorgen, Cynthia, Lemke, Johannes, von Karstedt, Silvia, Fritsch, Jürgen, Trauzold, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721811/ https://www.ncbi.nlm.nih.gov/pubmed/31416165 http://dx.doi.org/10.3390/cancers11081167 |
Ejemplares similares
-
TRAIL-receptor 2—a novel negative regulator of p53
por: Willms, Anna, et al.
Publicado: (2021) -
Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells
por: Willms, Anna, et al.
Publicado: (2019) -
Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy
por: Kretz, Anna-Laura, et al.
Publicado: (2018) -
Getting TRAIL back on track for cancer therapy
por: Lemke, J, et al.
Publicado: (2014) -
Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2
por: Bertsch, U, et al.
Publicado: (2014)